Weekly News Recap #Phispers
FDA rejects first MDMA therapy to treat PTSD; Merck, Curon ink up to US$ 1.3 bn deal for next-gen bispecific antibody
The US Food and Drug Administration (FDA) has declined to approve an MDMA-assisted therapy from Lykos Therapeutics to treat pos...
Impressions : 1815
Lilly’s Alzheimer’s drug gets FDA nod; GSK buys rights to mRNA vaccines from Curevac for US$ 1.56 bn
This week, the US Food and Drug Administration (FDA) finally approved Eli Lilly’s Alzheimer’s drug donanemab after ...
Impressions : 1235
Sanofi, Roche, Sobi, Avantor – a big week for M&As; JAK inhibitors to carry heart safety, cancer warnings
This week, Phispers brings you news on Pfizer’s Xeljanz, which underwent a post-approval study. Post the study, the ...
Impressions : 2244
US, EU announce plans to fortify drug supply chains; FDA authorizes J&J’s single shot vaccine
This week, Phispers brings you news on how the pandemic has compelled both the US and the EU to focus on strengthening their su...
Impressions : 2115
Pfizer shifts timeline of Covid vaccine to November; Remdesivir slumps in WHO’s Solidarity Trial
This week, Phispers has more updates on experimental Covid-19 vaccines and treatments.
Gilead’s remdesivir, which bagge...
Impressions : 59937
FDA hikes ANDA, DMF application fee; Sanofi faces charges of manslaughter in France
This week, Phispers brings you the user fee FDA will collect in FY 2021 from drug makers, CMOs and medical device makers.
In ...
Impressions : 74691

